The collaboration will be mutually beneficial - partners will both give and gain. The treatment of malaria is particularly problematical because of increasing drug resistance and virtual abandonment of tropical diseases research by the pharmaceutical industry. JPMW is one of a number of initiatives that have sprung up in recent years to combat the threat of malaria. As with these other enterprises, TDR has been involved with the JPMW right from the beginning, since initial discussions in Japan in 1995.
Japanese companies join international fight against malaria.
By Asako Saegusa.